[1] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版). 实用肝脏病杂志, 2019, 22(02):164-171. [2] Shi Y, Zheng M. Hepatitis B virus persistence and reactivation. BMJ, 2020, 370:m2200. [3] Brohi ZP, Sadaf A, Perveen U. Etiology, clinical features and outcome of fulminant hepatic failure in pregnancy. J Pak Med Assoc, 2013, 63(9):1168-1171. [4] Bajaj JS, O'leary JG, Lai JC, et al. Acute-on-chronic liver failure clinical guidelines. Am J Gastroenterol, 2022, 117(2):225-252. [5] Wang F, Sun W, Xiao Q, et al. Peripheral T lymphocytes predict the severity and prognosis in patients with HBV-related acute-on-chronic liver failure. Medicine (Baltimore), 2021, 100(5):e24075. [6] Nogueiro J, Santos-Sousa H, Pereira A, et al. The impact of the prognostic nutritional index (PNI) in gastric cancer. Langenbecks Arch Surg, 2022, 407(7):2703-2714. [7] Öcal L, Keskin M, Cerşit S, et al. Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction. Coron Artery Dis, 2022, 33(4):251-260. [8] Wang D, Hu X, Xiao L, et al. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg, 2021, 25(2):421-427. [9] 王贵强, 王福生, 庄辉, 等. 慢性乙型肝炎防治指南(2019年版). 中国病毒病杂志, 2020, 10(1):1-25. [10] Zhang J, Xiao X, Wu Y, et al. Prognostic nutritional index as a predictor of diabetic nephropathy progression. Nutrients, 2022, 14(17):1101-1104. [11] Dalkılınç Hökenek U, Kılıç M, Alışkan H. Investigation of the prognostic role of systemic immunoinflammatory index in patients with acute pancreatitis. Ulusal travma ve acil cerrahi dergisi. TJTES, 2023, 29(3):316-320. [12] Chen T, Yang Z, Choudhury AK, et al. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region. Hepatol Int, 2019, 13(6):695-705. [13] 王明强,牛垚飞,王生锋.慢加急性乙型肝炎肝衰竭患者血清聚集素水平变化及其临床意义探讨.实用肝脏病杂志,2022,25(5):677-680. [14] Lee HA, Jung JY, Lee YS, et al. Direct bilirubin is more valuable than total bilirubin for predicting prognosis in patients with liver cirrhosis. Gut Liver, 2021, 15(4):599-605. [15] 邓珂欣,罗红春.常用血液学指标评定慢加急性肝衰竭患者并发细菌感染和预后价值研究.实用肝脏病杂志,2023,26(2):242-245. [16] Nagai T, Nagaoka M, Tanimoto K, et al. Relationship between potentially inappropriate medications and functional prognosis in elderly patients with distal radius fracture: a retrospective cohort study. J Orthop Surg Res, 2020, 15(1):321. [17] Li Y, Wang WB, Yang L, et al. The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy. Nutrition, 2022, 93:111464. [18] Rui F, Yang H, Guo Z, et al. Derivation and validation of prognostic models for predicting survival outcomes in Acute-on-chronic liver failure patients. J Viral Hepat, 2021, 28(12):1719-1728. [19] Shalimar H, Rout G, Kumar R, et al. Persistent or incident hyperammonemia is associated with poor outcomes in acute decompensation and acute-on-chronic liver failure. JGH Open, 2020, 4(5):843-850. [20] Li J, Hu CH, Chen Y, et al. Characteristics of peripheral lymphocyte subsets in patients with acute-on-chronic liver failure associated with hepatitis B. Front Med (Lausanne), 2021, 8:689865. [21] Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: A systematic review and Meta-analysis of observational studies. Medicine, 2016, 95(8):e2877. [22] Ruf A, Dirchwolf M, Freeman RB. From Child-Pugh to MELD score and beyond: Taking a walk down memory lane. Ann Hepatol, 2022, 27(1):100535. |